Reversal of rivaroxaban anticoagulation by nonactivated prothrombin complex concentrate in urgent surgery.

about

Reversal of rivaroxaban anticoagulation by nonactivated prothrombin complex concentrate in urgent surgery.

Item

http://www.wikidata.org/entity/Q38993962

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Reversal of rivaroxaban antico ...... concentrate in urgent surgery.

@en

type

Item

label

Reversal of rivaroxaban antico ...... concentrate in urgent surgery.

@en

prefLabel

Reversal of rivaroxaban antico ...... concentrate in urgent surgery.

@en

P1476

Reversal of rivaroxaban antico ...... concentrate in urgent surgery.

@en

P2093

Carolina Chic Acevedo

http://www.w3.org/2001/XMLSchema#string

Francisco Velasco

http://www.w3.org/2001/XMLSchema#string

P2860

Reversal of rivaroxaban and dabigatran by prothrombin complex concentrate: a randomized, placebo-controlled, crossover study in healthy subjects

2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association

Rivaroxaban versus warfarin in nonvalvular atrial fibrillation

Oral rivaroxaban for symptomatic venous thromboembolism

A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey.

Rivaroxaban versus enoxaparin for thromboprophylaxis after hip arthroplasty.

Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty.

Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation.

Rivaroxaban: a once-daily anticoagulant for the prevention of thromboembolic complications.

Correlation of coagulation markers and 4F-PCC-mediated reversal of rivaroxaban in a rabbit model of acute bleeding.

P304

525-529

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2217/FCA.15.38

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

C Herrera

P577

2015-06-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26090568

http://www.w3.org/2001/XMLSchema#string

P921

anticoagulation